PAVmed Common Stock Total Equity History

PAVM Stock  USD 9.00  -0.17  -1.85%   
Common Stock Total Equity stood at 98.9 K as of December 31, 2025. This metric is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Over the last 16 observed reporting periods, this metric has followed a consistent upward trajectory with strong statistical fit (R² 0.87). Complete Financial Overview
 
Common Stock Total Equity  
 First Reported
2015-03-31
 Previous Quarter
101 K
 Current Value
109 K
 Quarterly Volatility
32.3 K
Macro event markers
 
Yuan Drop
 
Covid
 
Interest Hikes

Latest PAVmed Common Stock Total Equity Growth Pattern

Common Stock Total Equity10 Years Trend
Consistent Growth
   Common Stock Total Equity   
       Timeline  

Common Stock Total Equity Trend Statistics

PAVmed reports Common Stock Total Equity with a coefficient of variation of 82.7% over 9 periods, reflecting wide dispersion driven primarily by directional growth rather than instability. R-squared at 0.87 is consistent with a strong linear fit indicating consistent directional movement.
Arithmetic Mean 45,458
Geometric Mean 30,162
Coefficient Of Variation 82.71
Mean Deviation 34,417
Median 27,143
Standard Deviation 37,600
Sample Variance1.4B
Range93K
R-Value 0.93
Mean Square Error193.9M
R-Squared 0.87
Slope 6,951
Total Sum of Squares22.6B

PAVmed Common Stock Total Equity History

PAVmed's Common Stock Total Equity is tracked from 2015 through 2026, spanning 9 reported values, moving from 12.2 K to 103.8 K.
2026103.8 K
202598.9 K
202186 K
202064 K
201940.5 K
201827.1 K
201714.6 K
201613.3 K
201512.2 K

Correlation of Common Stock Total Equity With Other Accounts

Below are pairwise correlations of PAVmed's Common Stock Total Equity with other financial line items. Coefficients range from −1 (perfect inverse) to +1 (perfect co-movement). These values describe historical association and do not imply causation.

Related Fundamentals

Last ReportedEnd Of Year Estimate
Common Stock Shares Outstanding670.5 K1.2 M
Common Stock 1,000.00 950.00
Net Loss-80.3 M-76.3 M

Methodology, Assumptions & Data Sources

The data below presents PAVmed's Common Stock Total Equity through recent fiscal years. Cross-referencing this metric with adjacent financial statement accounts provides additional explanatory context. PAVmed's Common Stock Total Equity is shaped by the balance between retained earnings, shareholder distributions, and equity financing decisions.

Reported values for PAVmed Inc are derived from periodic company reporting and market reference feeds and standardized for analysis. Reference data and historical patterns are presented and do not constitute an investment recommendation or advice.

Editorial review and methodology oversight provided by: Ellen Johnson, Member of Macroaxis Editorial Board